Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Frontiers in Immunology
|
May 28, 2020
Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
Margaux Lejeune, Murat Cem Köse, Elodie Duray, et al.
Cancers
|
July 2, 2021
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma
Margaux Lejeune, Elodie Duray, Matthias Peipp, et al.
EJNMMI Radiopharmacy and Chemistry
|
July 1, 2026
High-yield, standardised automated radiosynthesis process for routine clinical insulinoma PET with [⁶⁸Ga]Ga-NODAGA-exendin-4
Elodie Duray, Matthieu Sacrez, Marine Hawotte, et al.
Leukemia & Lymphoma
|
June 3, 2017
Molecular mechanisms, current management and next generation therapy in myeloma bone disease
Roy Heusschen, Joséphine Muller, Elodie Duray, et al.
Journal of Hematology & Oncology
|
November 3, 2021
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma
Elodie Duray, Margaux Lejeune, Frederic Baron, et al.
Frontiers in Immunology
|
July 22, 2022
Radiotheranostic Agents in Hematological Malignancies
Jo Caers, Elodie Duray, Louise Vrancken, et al.
Hemasphere
|
June 26, 2023
Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma
Margaux Lejeune, Murat Cem Köse, Mégane Jassin, et al.
British Journal of Haematology
|
April 2, 2020
The anti-mitotic agents PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma but challenge the role of BMI-1 as an essential tumour gene
Arnold Bolomsky, Joséphine Muller, Kathrin Stangelberger, et al.
Cancers
|
March 1, 2019
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts
Joséphine Muller, Elodie Duray, Margaux Lejeune, et al.
Haematologica
|
May 12, 2018
Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease
Joséphine Muller, Arnold Bolomsky, Sophie Dubois, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Frontiers in Immunology
|
May 28, 2020
Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
Margaux Lejeune, Murat Cem Köse, Elodie Duray, et al.
Cancers
|
July 2, 2021
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma
Margaux Lejeune, Elodie Duray, Matthias Peipp, et al.
EJNMMI Radiopharmacy and Chemistry
|
July 1, 2026
High-yield, standardised automated radiosynthesis process for routine clinical insulinoma PET with [⁶⁸Ga]Ga-NODAGA-exendin-4
Elodie Duray, Matthieu Sacrez, Marine Hawotte, et al.
Leukemia & Lymphoma
|
June 3, 2017
Molecular mechanisms, current management and next generation therapy in myeloma bone disease
Roy Heusschen, Joséphine Muller, Elodie Duray, et al.
Journal of Hematology & Oncology
|
November 3, 2021
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma
Elodie Duray, Margaux Lejeune, Frederic Baron, et al.
Frontiers in Immunology
|
July 22, 2022
Radiotheranostic Agents in Hematological Malignancies
Jo Caers, Elodie Duray, Louise Vrancken, et al.
Hemasphere
|
June 26, 2023
Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma
Margaux Lejeune, Murat Cem Köse, Mégane Jassin, et al.
British Journal of Haematology
|
April 2, 2020
The anti-mitotic agents PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma but challenge the role of BMI-1 as an essential tumour gene
Arnold Bolomsky, Joséphine Muller, Kathrin Stangelberger, et al.
Cancers
|
March 1, 2019
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts
Joséphine Muller, Elodie Duray, Margaux Lejeune, et al.
Haematologica
|
May 12, 2018
Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease
Joséphine Muller, Arnold Bolomsky, Sophie Dubois, et al.
Page
of 1